Navigation Links
Phase 2 Trial of Lexicon's LX1032, Telotristat Etiprate, Shows Positive Results in Carcinoid Syndrome
Date:8/9/2011

telotristat etiprate in mild to moderate ulcerative colitis.

About Carcinoid Syndrome

Carcinoid syndrome is a chronic condition caused by metastatic neuroendocrine tumors that usually originate from the gastrointestinal tract.  These tumors secrete large amounts of serotonin, which can cause a variety of symptoms including severe diarrhea and abdominal discomfort.  Patients with carcinoid syndrome currently have limited therapeutic options, and the standard of care includes chronic therapy with somatostatin analogues, which are delivered by injection.  With current therapy, the gastrointestinal symptoms return over time in most patients, hence the need for new agents.    

About Lexicon

Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease.  Lexicon currently has four drug candidates in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid arthritis, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its broad pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking statements," including statements relating to Lexicon's clinical development of LX1032 (telotristat etiprate), including characterizations of the results of and projected timing of clinical trials, and the potential therapeutic and commercial potential of LX1032. This press release also contains forward-looking statements relating to Lexicon's growth and future operating results, discove
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... According to a new market ... (Endoscopes, Endoscopic Operative Devices, and Visualization Systems) - Global ... the global endoscopy devices market was valued at USD ... at a CAGR of 6.8% from 2013 to 2019, ... in 2019. Browse the full Endoscopy Devices Market ...
(Date:7/10/2014)... , July 11, 2014  Major advances ... of cancer are being highlighted in a three-day ... from 10-12 July, 2014.  Renowned national and ... share best practices and exchange knowledge on modern ... accurate and efficient. The Summit ...
(Date:7/10/2014)... 2014  RESMED INC. (NYSE: RMD ) today ... year ended June 30, 2014 results on Thursday, July 31, ... press release with ResMed,s results will be issued after 1:00 ... webcast to discuss operating results and future outlook. ... US Pacific Time and the live webcast of the call ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2
... 19 CareFusion (NYSE: CFN ), a leading, global ... 3,900 CareFusion LTV® 1200 ventilators ordered by the Centers for ... strategic national stockpile. , The CDC ordered a total of ... is the nation,s reserve of medical products used in the ...
... Annual Convention -- Mirixa Corporation, ... announced the launch of MirixaEdge(SM). Previewed to independent pharmacists ... enables pharmacists to design their own patient care programs ... employer, or age. , MirixaEdge capitalizes on the nation,s ...
Cached Medicine Technology:CareFusion Shipping Ventilators to CDC for National Emergency Preparedness 2Mirixa Corporation Announces MirixaEdge(SM) 2
(Date:7/13/2014)... (PRWEB) July 13, 2014 Athletes with ... recovery period from concussions, according to research presented today ... AOSSM ) Annual Meeting. The research marks the first ... based on the known physical events that occur after ... with a long allele in the (GT)n genotype were ...
(Date:7/13/2014)... July 13, 2014 Fadhits.com is popular ... prom dresses are extremely beautiful. Recently, the company has ... for 2014. What’s more, all these outfits are ... off). , Additionally, the supplier is now offering ... elegant Quinceanera dresses, it has many other designs for ...
(Date:7/13/2014)... Wright & Schulte LLC has learned ... in July of 2015, in U.S. District Court, District ... the discovery process in the South Carolina federal ... over the multidistrict litigation (MDL). The complaints pending in ... who allege that they took the statin medication to ...
(Date:7/13/2014)... MI (PRWEB) July 13, 2014 If Dr. ... program he has just launched at http://www.HealthYourself101.com will ... visceral obesity. , Power has set out to provide ... ill effects that’s actually – dare we say it? – ... program,” says Power, “aims to engage the remote learner – ...
(Date:7/12/2014)... a well-known wedding dress manufacturer and retailer, has added a ... its product line. In addition, the company has launched a ... more benefits for its loyal fans. All its brand ... 72% off. , As a leader in the garment industry, ... a good place for ladies who want to purchase charming ...
Breaking Medicine News(10 mins):Health News:Genetic Factors May Be Responsible for Slowing Concussion Recovery in Athletes 2Health News:Fadhits.com Announces a Special Offer on Elegant Quinceanera Dresses 2Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 2Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 3Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 4Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 2Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 3Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 4Health News:New Collection of Long Graduation Dresses Revealed by Fadhits.com 2
... A genomic study of chronic blood cancer - a precursor ... diagnosis using only a blood test, avoiding the need for ... the Wellcome Trust Sanger Institute identified the SF3B1 gene as ... forms of blood cancer. Myelodysplasia is particularly prevalent among people ...
... Alan Mozes HealthDay Reporter , MONDAY, Sept. 26 ... Dinora Rodriguez. "It was a nightmare." Rodriguez had woken ... not move her arms or even close her eyes. And ... case involving breast implants and a facial scar, gone terribly ...
... Maureen Salamon HealthDay Reporter , MONDAY, Sept. 26 ... half of U.S. primary care physicians believe their own patients ... randomly selected from the American Medical Association Physician Masterfile showed ... too much medical care, while 52 percent think the amount ...
... A large-scale data review by researchers in China of ... the endoscopic procedure to be safe and effective for ... a pooled detection rate of 68.1 percent for all ... be the most common indication, with a relatively high ...
... HealthDay Reporter , MONDAY, Sept. 26 (HealthDay News) ... and radiation, can seriously disrupt a couple,s sex life. ... and women figure out what sorts of treatments for erectile ... during sex. In doing so, they returned some luster to ...
... DiabetesIQ, released this week, challenges people to test their ... as they learn about the complexities of the disease, ... million Californians. Developed as a free download by ... Center and QuantiaMD, a company headquartered in Waltham, Massachusetts, ...
Cached Medicine News:Health News:Researchers uncover gene associated with blood cancers 2Health News:Researchers uncover gene associated with blood cancers 3Health News:Check Plastic Surgeon's Credentials or Risk Tragic Results, Experts Warn 2Health News:Check Plastic Surgeon's Credentials or Risk Tragic Results, Experts Warn 3Health News:Check Plastic Surgeon's Credentials or Risk Tragic Results, Experts Warn 4Health News:Many Doctors Think Patients Get Over-Treated, Study Says 2Health News:Many Doctors Think Patients Get Over-Treated, Study Says 3Health News:Study examining large-scale data of double balloon enteroscopy shows it is safe and effective 2Health News:Study examining large-scale data of double balloon enteroscopy shows it is safe and effective 3Health News:Study examining large-scale data of double balloon enteroscopy shows it is safe and effective 4Health News:Couples Counseling Boosts Sex Lives After Prostate Cancer 2Health News:Couples Counseling Boosts Sex Lives After Prostate Cancer 3Health News:Couples Counseling Boosts Sex Lives After Prostate Cancer 4Health News:Interactive mobile app from UCSF and QuantiaMD teaches people how to manage diabetes 2Health News:Interactive mobile app from UCSF and QuantiaMD teaches people how to manage diabetes 3
... simplified focusing guidance system has ... to use of its type. Technicians ... LM-770 with a minimum of instruction. ... target lines to focus first. A ...
... is the newest generation of electronic refractors. The ... control the refractor from a keypad that is small ... controls the CP-670 Automatic Chart Projector. The TRS is ... all the lenses are moved for you, taking you ...
The Electric H-Base Table is for heavier instruments, or for those who prefer electric elevation. The electric table easily accepts a slit lamp, a single tabletop, or a double tabletop, just as the M...
The Manual Table Base is elevated with an easy to reach elevating wheel for smooth operation. The table base will accept a slit lamp, a single table top, or a double tabletop for more than one instru...
Medicine Products: